UCB SA (UNC.DE) Fundamental Analysis & Valuation

FRA:UNC • BE0003739530

Current stock price

252.2 EUR
-0.8 (-0.32%)
Last:

This UNC.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. UNC.DE Profitability Analysis

1.1 Basic Checks

  • UNC had positive earnings in the past year.
  • UNC had a positive operating cash flow in the past year.
  • UNC had positive earnings in each of the past 5 years.
  • UNC had a positive operating cash flow in each of the past 5 years.
UNC.DE Yearly Net Income VS EBIT VS OCF VS FCFUNC.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

1.2 Ratios

  • UNC has a better Return On Assets (8.58%) than 63.46% of its industry peers.
  • UNC has a Return On Equity (14.34%) which is in line with its industry peers.
  • UNC has a Return On Invested Capital of 10.29%. This is comparable to the rest of the industry: UNC outperforms 57.69% of its industry peers.
  • UNC had an Average Return On Invested Capital over the past 3 years of 5.76%. This is significantly below the industry average of 14.90%.
  • The 3 year average ROIC (5.76%) for UNC is below the current ROIC(10.29%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 8.58%
ROE 14.34%
ROIC 10.29%
ROA(3y)5.64%
ROA(5y)5.4%
ROE(3y)9.59%
ROE(5y)9.2%
ROIC(3y)5.76%
ROIC(5y)5.83%
UNC.DE Yearly ROA, ROE, ROICUNC.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10

1.3 Margins

  • UNC has a Profit Margin of 20.13%. This is in the better half of the industry: UNC outperforms 75.00% of its industry peers.
  • In the last couple of years the Profit Margin of UNC has grown nicely.
  • Looking at the Operating Margin, with a value of 25.98%, UNC is in the better half of the industry, outperforming 65.38% of the companies in the same industry.
  • UNC's Operating Margin has improved in the last couple of years.
  • UNC's Gross Margin of 74.29% is fine compared to the rest of the industry. UNC outperforms 67.31% of its industry peers.
  • UNC's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 25.98%
PM (TTM) 20.13%
GM 74.29%
OM growth 3Y27.72%
OM growth 5Y4.58%
PM growth 3Y38.49%
PM growth 5Y8.01%
GM growth 3Y2.17%
GM growth 5Y-0.06%
UNC.DE Yearly Profit, Operating, Gross MarginsUNC.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

7

2. UNC.DE Health Analysis

2.1 Basic Checks

  • UNC has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • The number of shares outstanding for UNC remains at a similar level compared to 1 year ago.
  • Compared to 5 years ago, UNC has more shares outstanding
  • Compared to 1 year ago, UNC has an improved debt to assets ratio.
UNC.DE Yearly Shares OutstandingUNC.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
UNC.DE Yearly Total Debt VS Total AssetsUNC.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • UNC has an Altman-Z score of 5.58. This indicates that UNC is financially healthy and has little risk of bankruptcy at the moment.
  • UNC has a Altman-Z score of 5.58. This is amongst the best in the industry. UNC outperforms 82.69% of its industry peers.
  • UNC has a debt to FCF ratio of 1.22. This is a very positive value and a sign of high solvency as it would only need 1.22 years to pay back of all of its debts.
  • With an excellent Debt to FCF ratio value of 1.22, UNC belongs to the best of the industry, outperforming 88.46% of the companies in the same industry.
  • UNC has a Debt/Equity ratio of 0.20. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of UNC (0.20) is better than 75.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 1.22
Altman-Z 5.58
ROIC/WACC1.27
WACC8.1%
UNC.DE Yearly LT Debt VS Equity VS FCFUNC.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.3 Liquidity

  • A Current Ratio of 1.38 indicates that UNC should not have too much problems paying its short term obligations.
  • UNC's Current ratio of 1.38 is in line compared to the rest of the industry. UNC outperforms 42.31% of its industry peers.
  • UNC has a Quick Ratio of 1.04. This is a normal value and indicates that UNC is financially healthy and should not expect problems in meeting its short term obligations.
  • UNC has a Quick ratio of 1.04. This is comparable to the rest of the industry: UNC outperforms 44.23% of its industry peers.
Industry RankSector Rank
Current Ratio 1.38
Quick Ratio 1.04
UNC.DE Yearly Current Assets VS Current LiabilitesUNC.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

7

3. UNC.DE Growth Analysis

3.1 Past

  • UNC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 100.60%, which is quite impressive.
  • UNC shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 13.26% yearly.
  • Looking at the last year, UNC shows a very strong growth in Revenue. The Revenue has grown by 25.83%.
  • The Revenue has been growing slightly by 7.68% on average over the past years.
EPS 1Y (TTM)100.6%
EPS 3Y31.73%
EPS 5Y13.26%
EPS Q2Q%123.53%
Revenue 1Y (TTM)25.83%
Revenue growth 3Y11.95%
Revenue growth 5Y7.68%
Sales Q2Q%26.57%

3.2 Future

  • UNC is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.75% yearly.
  • Based on estimates for the next years, UNC will show a quite strong growth in Revenue. The Revenue will grow by 10.92% on average per year.
EPS Next Y2.96%
EPS Next 2Y15.35%
EPS Next 3Y17.69%
EPS Next 5Y16.75%
Revenue Next Year11.84%
Revenue Next 2Y12.38%
Revenue Next 3Y12.24%
Revenue Next 5Y10.92%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
UNC.DE Yearly Revenue VS EstimatesUNC.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B
UNC.DE Yearly EPS VS EstimatesUNC.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10 20 30

2

4. UNC.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 25.25 indicates a quite expensive valuation of UNC.
  • Based on the Price/Earnings ratio, UNC is valued a bit more expensive than 61.54% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 25.96, UNC is valued at the same level.
  • With a Price/Forward Earnings ratio of 24.52, UNC is valued on the expensive side.
  • The rest of the industry has a similar Price/Forward Earnings ratio as UNC.
  • UNC's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 24.04.
Industry RankSector Rank
PE 25.25
Fwd PE 24.52
UNC.DE Price Earnings VS Forward Price EarningsUNC.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of UNC is on the same level as its industry peers.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of UNC is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 26.63
EV/EBITDA 18.17
UNC.DE Per share dataUNC.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • UNC has a very decent profitability rating, which may justify a higher PE ratio.
  • UNC's earnings are expected to grow with 17.69% in the coming years. This may justify a more expensive valuation.
PEG (NY)8.53
PEG (5Y)1.9
EPS Next 2Y15.35%
EPS Next 3Y17.69%

4

5. UNC.DE Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.39%, UNC is not a good candidate for dividend investing.
  • UNC's Dividend Yield is comparable with the industry average which is at 1.92.
  • Compared to an average S&P500 Dividend Yield of 1.91, UNC's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.39%

5.2 History

  • The dividend of UNC has a limited annual growth rate of 2.20%.
Dividend Growth(5Y)2.2%
Div Incr YearsN/A
Div Non Decr YearsN/A
UNC.DE Yearly Dividends per shareUNC.DE Yearly Dividends per shareYearly Dividends per share 2026 0.5 1

5.3 Sustainability

  • UNC pays out 16.94% of its income as dividend. This is a sustainable payout ratio.
  • The dividend of UNC is growing, but earnings are growing more, so the dividend growth is sustainable.
DP16.94%
EPS Next 2Y15.35%
EPS Next 3Y17.69%
UNC.DE Yearly Income VS Free CF VS DividendUNC.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
UNC.DE Dividend Payout.UNC.DE Dividend Payout, showing the Payout Ratio.UNC.DE Dividend Payout.PayoutRetained Earnings

UNC.DE Fundamentals: All Metrics, Ratios and Statistics

UCB SA

FRA:UNC (3/16/2026, 7:00:00 PM)

252.2

-0.8 (-0.32%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-26
Earnings (Next)07-21
Inst Owners40.45%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap49.06B
Revenue(TTM)7.74B
Net Income(TTM)1.56B
Analysts75.56
Price Target283.04 (12.23%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.39%
Yearly Dividend1.39
Dividend Growth(5Y)2.2%
DP16.94%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.51%
PT rev (3m)11.7%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.02%
EPS NY rev (3m)1.16%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)1.32%
Revenue NY rev (3m)3.27%
Valuation
Industry RankSector Rank
PE 25.25
Fwd PE 24.52
P/S 6.34
P/FCF 26.63
P/OCF 21.41
P/B 4.51
P/tB 21.06
EV/EBITDA 18.17
EPS(TTM)9.99
EY3.96%
EPS(NY)10.29
Fwd EY4.08%
FCF(TTM)9.47
FCFY3.75%
OCF(TTM)11.78
OCFY4.67%
SpS39.8
BVpS55.87
TBVpS11.97
PEG (NY)8.53
PEG (5Y)1.9
Graham Number112.06
Profitability
Industry RankSector Rank
ROA 8.58%
ROE 14.34%
ROCE 14.62%
ROIC 10.29%
ROICexc 12.64%
ROICexgc 53.22%
OM 25.98%
PM (TTM) 20.13%
GM 74.29%
FCFM 23.8%
ROA(3y)5.64%
ROA(5y)5.4%
ROE(3y)9.59%
ROE(5y)9.2%
ROIC(3y)5.76%
ROIC(5y)5.83%
ROICexc(3y)6.83%
ROICexc(5y)6.79%
ROICexgc(3y)30.47%
ROICexgc(5y)36.26%
ROCE(3y)8.18%
ROCE(5y)8.29%
ROICexgc growth 3Y18.32%
ROICexgc growth 5Y-5.98%
ROICexc growth 3Y44.94%
ROICexc growth 5Y7.84%
OM growth 3Y27.72%
OM growth 5Y4.58%
PM growth 3Y38.49%
PM growth 5Y8.01%
GM growth 3Y2.17%
GM growth 5Y-0.06%
F-Score9
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 1.22
Debt/EBITDA 0.83
Cap/Depr 71.61%
Cap/Sales 5.8%
Interest Coverage 15.71
Cash Conversion 86.85%
Profit Quality 118.23%
Current Ratio 1.38
Quick Ratio 1.04
Altman-Z 5.58
F-Score9
WACC8.1%
ROIC/WACC1.27
Cap/Depr(3y)55.86%
Cap/Depr(5y)76.64%
Cap/Sales(3y)5.68%
Cap/Sales(5y)6.46%
Profit Quality(3y)111.45%
Profit Quality(5y)122.7%
High Growth Momentum
Growth
EPS 1Y (TTM)100.6%
EPS 3Y31.73%
EPS 5Y13.26%
EPS Q2Q%123.53%
EPS Next Y2.96%
EPS Next 2Y15.35%
EPS Next 3Y17.69%
EPS Next 5Y16.75%
Revenue 1Y (TTM)25.83%
Revenue growth 3Y11.95%
Revenue growth 5Y7.68%
Sales Q2Q%26.57%
Revenue Next Year11.84%
Revenue Next 2Y12.38%
Revenue Next 3Y12.24%
Revenue Next 5Y10.92%
EBIT growth 1Y40.24%
EBIT growth 3Y42.99%
EBIT growth 5Y12.61%
EBIT Next Year63.05%
EBIT Next 3Y33.01%
EBIT Next 5Y25.45%
FCF growth 1Y100.22%
FCF growth 3Y35.04%
FCF growth 5Y20.27%
OCF growth 1Y84.46%
OCF growth 3Y26.98%
OCF growth 5Y16.21%

UCB SA / UNC.DE Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for UCB SA?

ChartMill assigns a fundamental rating of 6 / 10 to UNC.DE.


What is the valuation status of UCB SA (UNC.DE) stock?

ChartMill assigns a valuation rating of 2 / 10 to UCB SA (UNC.DE). This can be considered as Overvalued.


Can you provide the profitability details for UCB SA?

UCB SA (UNC.DE) has a profitability rating of 7 / 10.


What is the valuation of UCB SA based on its PE and PB ratios?

The Price/Earnings (PE) ratio for UCB SA (UNC.DE) is 25.25 and the Price/Book (PB) ratio is 4.51.


Can you provide the financial health for UNC stock?

The financial health rating of UCB SA (UNC.DE) is 7 / 10.